Carnot to Invest US$188 Million in Hidalgo
Carnot Laboratories inaugurated its new Plata Plant in the municipality of Villa de Tezontepec, Hidalgo, with an initial investment of US$129 million, which is expected to increase to US$188 million following additional expansion phases.
The pharmaceutical complex is built on a site covering 83,000 m², with approximately 21,000 m² of floor space distributed among five buildings dedicated to production, laboratories, storage, services, and administration.
The facility has the capacity to produce 35 million units of finished products annually, including 500 million tablets, 105 million capsules, and 15 million bottles, expanding the company’s pharmaceutical production for both domestic and international markets.
During the inauguration, Guy Jean Savoir, chairman of the board of directors of Laboratorios Carnot and CANIFARMA, said the project is expected to create 600 highly specialized direct jobs and 5,000 indirect jobs. Approximately 1,500 workers from various fields participated in the construction of the facility.
The company has also announced two additional investment phases. The next phase will include a facility specializing in hormonal injectables, while the subsequent phase will focus on the production of liquid and semisolid medications.
Carnot currently exports to 18 countries and aims to expand its international presence by increasing production capacity and obtaining additional regulatory certifications. The facility will produce medicines in various formulations for therapeutic areas including gastroenterology, respiratory health, and the nervous system.
The opening ceremony was attended by Mexican President Claudia Sheinbaum Pardo and Hidalgo Governor Julio Menchaca Salazar.
Located in Platah Industrial Park, the complex provides access to Felipe Ángeles International Airport, the Arco Norte highway, and the Mexico City–Pachuca Highway, all of which are key to the distribution of pharmaceutical products.
This infrastructure will enable Laboratorios Carnot to expand its manufacturing capacity in Mexico while providing a platform for new production lines, specialized job creation, and access to international markets.
